Prominent publications by Manuella Bonmarchand

KOL Index score: 8328

OBJECTIVES: Mutations usually associated with zidovudine exposure have been observed in zidovudine-naive patients treated by stavudine in combination. These mutations were named thymidine analogue mutations (TAMs). This fact, combined with phenotypical and biochemical findings provided additional evidence for cross-resistance between zidovudine and stavudine. A recent genotypic study in naive patients receiving stavudine/didanosine combination showed emergence of TAMs and a ...

Also Ranks for: Thymidine Analogue Mutations |  reverse transcriptase |  naive patients |  stavudine lamivudine |  antiretroviral therapy

Key People For Thymidine Analogue Mutations

Top KOLs in the world
Daniel * *********
antiretroviral therapy virologic failure south africa
Victoria **** *******
drug resistance mutations resistance testing reverse transcriptase
Douglas * ********
antiretroviral therapy hiv infection human immunodeficiency virus
Joseph * ****
antiretroviral therapy united states hiv infection
Mark * ********
reverse transcriptase immunodeficiency virus resistance mutations
Françoise ************
virological response viral load resistance mutations

Manuella Bonmarchand:Expert Impact

Concepts for whichManuella Bonmarchandhas direct influence:Thymidine analogue mutations,  Stavudine lamivudine,  Viral drug therapy,  Thymidine analogue,  Analogue mutations,  Antiretroviralnaive patients,  Receiving stavudine,  Resistance mutations.

Manuella Bonmarchand:KOL impact

Concepts related to the work of other authors for whichfor which Manuella Bonmarchand has influence:Resistance mutations,  Virological failure,  Cd4 cell count,  Yxdd motif,  M184v mutation,  Salvage therapy,  Treatment resumption.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

Departments of Virology, Infectious Diseases and Internal Medecine, Pitié-Salpêtrière Hospital, Paris, France